Kiniksa Pharmaceuticals, Ltd. (KNSA)

Kiniksa Pharmaceuticals Revenue

Kiniksa Pharmaceuticals had revenue of $108.63M in the quarter ending June 30, 2024, with 51.99% growth. This brings the company's revenue in the last twelve months to $338.93M, up 20.69% year-over-year. In the year 2023, Kiniksa Pharmaceuticals had annual revenue of $270.26M with 22.74% growth.

• Revenue (ttm): $338.93M
• Revenue Growth: +20.69%
• P/S Ratio: 5.48
• Revenue / Employee: $1,141,178
• Employees: 297
• Market Cap: 1.86B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	270.26M	50.08M	22.74%
Dec 31, 2022	220.18M	181.64M	471.24%
Dec 31, 2021	38.54M	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.